About me
Charles Chase, PhD, currently holds the role as the Vice President of Technical Business Development at
Asymchem. Before joining Asymchem, he served as Vice President of Pharmaceutical Development at
Elicio Therapeutics and Senior Principal Scientist at Eisai Inc. With experience spanning over 20 years in
Chemistry, Manufacturing, and Controls (CMC), he possesses a deep understanding of process research
and development across various substances, including oligonucleotides, peptides, and complex small
molecules like Halaven®. His expertise encompasses synthesis, route optimization, CMC/CDMO
management, and navigating regulatory approval processes.